2 results
Approved WMOCompleted
Primary ObjectiveEstimate the proportion of subjects fulfilling criteria for symptomatic remission (as defined by Andreasen et al.)* following a transition to 12 months* treatment with flexible-dose PP3M in subjects with schizophrenia previously…
Approved WMOCompleted
Time to recurrence of sustained VT and/or appropriate ICD therapy; ATP or shock